Pertussis Vaccine | Shim Clinic, Singapore

Pertussis Vaccine | Shim Clinic, Singapore: Pertussis vaccine jab/shot/injection schedule, to vaccinate against the Bordetella pertussis, to immunise against Pertussis (whooping cough) clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

All travellers should be up to date with vaccination according to national recommendations. Both whole-cell (wP) and acellular (aP) pertussis vaccines provide excellent protection and are safe apart from minor adverse events. For several decades, wP vaccines have been widely used in national childhood vaccination programmes; aP vaccines, which cause fewer adverse events but are more expensive, are now licensed in many countries. Both wP and aP are usually administered in combination with diphtheria and tetanus toxoids (DTwP or DTaP). WHO recommends a 3-dose primary series, with the first dose administered at the age of 6 weeks; subsequent doses should be given 4–8 weeks apart, at 10–14 weeks and 14–18 weeks. The last dose of the recommended primary series should be completed by the age of 6 months. Protection declines with time and probably lasts only a few years. A booster dose administered 1–6 years after the primary series, preferably during the second year of life. Some countries now offer an adolescent/adult booster, in particular to health care workers and young parents. Previously unvaccinated adolescents/adults should receive 3 doses of wP vaccine or aP vaccine with an interval of 2 months between the first and second, and 6–12 months between the second and third doses.

Vaccine	Against	Disease	Age	D o s e s	Dose schedule	Price per dose (SG$)
Live attenuated
MMR vaccine			≥12m	1		$70/=
Measles vaccine	Measles virus	Measles
Mumps vaccine	Mumps virus	Mumps
Rubella vaccine	Rubella virus	Rubella
Varilrix™ Varicella vaccine Chickenpox vaccine	Varicella zoster virus HHV-3	Varicella Chickenpox	12m-12y	1		$121/=
Varilrix™ Varicella vaccine Chickenpox vaccine		Varicella Chickenpox	≥13y	2	6-10w interval	$121/=
Zostavax™ Herpes zoster vaccine Shingles vaccine		Herpes zoster Shingles	≥50y	1		$400/=
Stamaril® Yellow fever vaccine	Yellow fever virus	Yellow fever	9m-59y	1	10 yearly	$250/=
Inactivated / Whole / Viral & Bacterial
Ixiaro® Japanese encephalitis vaccine JE vaccine	Japanese encephalitis virus	Japanese encephalitis	≥17y	2	2nd: 28d after 1st	$386/=
Ixiaro® Japanese encephalitis vaccine JE vaccine	Japanese encephalitis virus	Japanese encephalitis	≥17y	1	Booster: 12-24m after 2nd	$386/=
Dukoral® Cholera vaccine	Vibrio cholerae	Cholera	2-6y	3	1-6w interval	$113/=
			2-6y	1	Booster: 6m after 3rd
			≥6y	2	1-6w interval
			≥6y	1	Booster: 2y after 2nd
Inactivated / Fractional / Protein
Intanza™ Influenza vaccine	Influenza virus	Influenza	18-59y	1	1 yearly	$30/=
Fluarix™ Influenza vaccine	Influenza virus	Influenza	6-36m	½	1 yearly	$30/=
Fluarix™ Influenza vaccine	Influenza virus	Influenza	>3y	1	1 yearly	$30/=
Tetavax Tetanus vaccine	Clostridium tetani	Tetanus	adults	3	1-2m interval 3rd @ 6-12m after 2nd	$30/=
Tetavax Tetanus vaccine	Clostridium tetani	Tetanus	booster	1	10 yearly	$30/=
Boostrix® Tdap vaccine DPT vaccine DTP vaccine			≥4y	1	<10 yearly	$70/=
Diphtheria vaccine	Corynebacterium diphtheriae	Diphtheria
Tetanus vaccine	Clostridium tetani	Tetanus
Pertussis vaccine Whooping cough vaccine	Bordetella pertussis	Pertussis Whooping cough
Inactivated / Fractional / Polysaccharide / Pure
Typhim Vi® Typhoid vaccine	Salmonella typhi	Typhoid fever	>5y	1	3 yearly	$40/=
Mencevax® ACWY MPSV4 Meningococcal Polysaccharide vaccine MPSV Meningococcal Meningitis vaccine Meningococcal vaccine Meningitis vaccine	Neisseria meningitidis types A, C, W-135 and Y	Meningococcal meningitis	>2y	1		$80/=
Inactivated / Fractional / Polysaccharide / Conjugate
Menactra® MCV4 Meningococcal conjugate vaccine MCV Meningococcal Meningitis vaccine Meningococcal vaccine Meningitis vaccine	Neisseria meningitidis types A, C, W-135 and Y	Meningococcal meningitis	2-55y	1		$220/=
Prevenar 13® (SG) / Prevnar 13® (US) PCV13 Pneumococcal conjugate vaccine PCV Pneumococcal Pneumonia vaccine Pneumococcal vaccine Pneumonia vaccine	Streptococcus pneumoniae types 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F	Pneumococcal infection	6w-6m	4	1m interval 4th @ 12-15m	$274/=
			7-11m	2	1m interval
			12-23m	2	2m interval
			2-5y	1
			≥50y	1

If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.

Vaccine	Against	Disease	Age	D o s e s	Dose schedule	Price per dose (SG$)
Havrix™ 1440 Adult Hepatitis A vaccine Hepatitis vaccine	Hepatitis A virus	Hepatitis A	≥19y	2	m 0 & 6-12	$90/=
Twinrix® Hepatitis vaccine	Hepatitis A virus Hepatitis B virus	Hepatitis A Hepatitis B	1-15y	2	m 0, 6-12	$120/=
			≥16y	3	m 0, 1, 6
			≥16y	4	d 0, 7, 21 & m 12
Inactivated / Fractional / Protein / Subunit / Recombinant
Engerix™-B 20 μg Hepatitis B vaccine Hepatitis vaccine	Hepatitis B virus	Hepatitis B	11-15y	2	m 0, & 6	$50/=
			≥20y	3	m 0, 1, & 6
			≥20y	4	m 0, 1, 2, & 12 or d 0, 7, 21 & m 12
Gardasil® HPV vaccine	HPV types 6, 11, 16, & 18	Genital warts Cervical cancer	9-26y	3	m 0, 2, & 6 or m 0, 1, & 4	$195/=
Cervarix® HPV vaccine	HPV types 16, & 18 (31, 33, & 45)		10-25y	3	m 0, 1, & 6 m 0, 1, & 5 m 0, 2½, 12	$195/=
V503 HPV vaccine	HPV types 6, 11, 16, 18, 31, 33, 45, 52, & 58			3	m 0, 2, & 6 or m 0, 1, & 4	$???/=

Vaccination against	Birth	1 month	3 months	4 months	5 months	12 months	15 months	18 months	6-7 years^	10-11 years^^
Tuberculosis	BCG
Hepatitis B	HepB (D1)	HepB (D2)			HepB (D3)#
Diphtheria, Tetanus, Pertussis			DTaP (D1)	DTaP (D2)	DTaP (D3)			DTaP (B1)		Tdap (B2)
Poliovirus			OPV (D1)	OPV (D2)	OPV (D3)			OPV (B1)	OPV (B2)	OPV (B3)
Measles, Mumps, Rubella						MMR (D1)	MMR (D2)##
Pneumococcal Disease			PCV (D1)		PCV (D2)	PCV (B1)
Human Papillomavirus		Recommended for females 9 to 26 years; three doses are required at intervals of 0, 2, 6 months
Influenza		Recommended annually for all children aged 6 months to <5 years and children aged 6 months to <18 years in high-risk groups

Notes:
BCG	Bacillus Calmette-Guérin
HepB	Hepatitis B vaccine
DTaP	Paediatric diphtheria and tetanus toxoid and acellular pertussis vaccine
Tdap	Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine
MMR	Measles, mumps, and rubella vaccine
OPV	Oral polio vaccine
PCV	Pneumococcal conjugate vaccine
D1/D2/D3	1st dose, 2nd dose, 3rd dose
B1/B2/B3	1st booster, 2nd booster, 3rd booster
^	Primary 1
^^	Primary 5


#	3rd dose of HepB can be given with the 3rd dose of DTaP and OPV for the convenience of parents.
##	2nd dose of MMR can be given between 15-18 months

DTaP Vaccine Supplies Will Be Limited for Summer 2013
Wed, 22 May 2013 19:40:00 +0100 | AAFP Health of the Public
For the second consecutive summer, the CDC is issuing guidance on immunizing children during an ongoing shortage of certain combination vaccines. According to a notice on the CDC website, Sanofi Pasteur's diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus influenzae (Source: AAFP Health of the Public)

In The Resurgence Of Whooping Cough, Leading Explanations Don't Stand Up To Scrutiny
Wed, 22 May 2013 07:00:00 +0100 | Health News from Medical News Today
Whooping cough has exploded in the United States and some other developed countries in recent decades, and many experts suspect ineffective childhood vaccines for the alarming resurgence. Some say the vaccine wears off quicker than public health officials had previously believed. Others suggest that the vaccine protects against illness but does not prevent transmission of the bacterial disease, which is also known as pertussis... (Source: Health News from Medical News Today)

Recommended Pertussis Vaccine is Less Effective
Wed, 22 May 2013 05:00:00 +0100 | Medical Headlines From Ivanhoe.com
(Ivanhoe Newswire) -- Whole-cell vaccines for pertussis have been found to be up to four times as effective as the acellular vaccine, the recommended vaccine since the late 1990s. (Source: Medical Headlines From Ivanhoe.com)

During CA Pertussis Outbreak, Whole-Cell Vaccine More Effective Than Acellular Vaccine
Tue, 21 May 2013 08:00:00 +0100 | Health News from Medical News Today
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics. Whole-cell pertussis vaccines, also called DTwP, were available from the 1940s to 1990s, but were associated with safety concerns that ultimately led to the development of acellular pertussis vaccines, which are also called DTaP. By the late 1990s, the United States had switched from whole-cell to acellular vaccines for all five recommended infant and childhood doses... (Source: Health News from Medical News Today)

Study Shows Whole-Cell Vaccine Was More Effective Than Acellular Vaccine During California Pertussis Outbreak
Tue, 21 May 2013 08:00:00 +0100 | Health News from Medical News Today
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics. Whole-cell pertussis vaccines, also called DTwP, were available from the 1940s to 1990s, but were associated with safety concerns that ultimately led to the development of acellular pertussis vaccines, which are also called DTaP. By the late 1990s, the United States had switched from whole-cell to acellular vaccines for all five recommended infant and childhood doses... (Source: Health News from Medical News Today)